Product Information
DILTIAZEM 90 MG TABLET is a generic product labeled by Oceanside Pharmaceuticals, priced at $0.0855 per EA under NDC 68682000850. Its NADAC has been published 457 times since Jan 4, 2017.
FDA first approved this application on Nov 5, 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
90 mg/1
Manufacturer
Oceanside PharmaceuticalsNDC
68682000850
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA018602FDA Approved
11/5/1982
TE Code
AB
On Market Since
12/25/2010
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 90 MG TABLET has been published 457 times since Jan 4, 2017, and over the history we have for it it has declined 71.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0855 per EA |
|---|---|
| All-time high | $0.2983 (Jan 11, 2017) |
| All-time low | $0.0855 (Sep 17, 2025) |
| Median price | $0.2519 |
| Average price | $0.2400 |
| Largest weekly change | +37.3% (Mar 20, 2024) |
| Weeks tracked | 457 |
| Tracking since | Jan 4, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-52.0%
5Y
-69.5%
All
-71.3%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diltiazem Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DILTIAZEM 90 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 90 MG TABLET, manufactured by Oceanside Pharmaceuticals, is $0.0855 per EA (NDC 68682000850), effective Oct 1, 2025.
How has the price of DILTIAZEM 90 MG TABLET changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 90 MG TABLET has declined 71.3%. It has been tracked across 457 weekly CMS publications since Jan 4, 2017.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 90 MG TABLET?
Since Jan 4, 2017, the NADAC for DILTIAZEM 90 MG TABLET has ranged from a low of $0.0855 (Sep 17, 2025) to a high of $0.2983 (Jan 11, 2017), with a median of $0.2519 per EA.
Are there cheaper alternatives to DILTIAZEM 90 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 90 MG TABLET, is $0.0699 per EA — about 18% below DILTIAZEM 90 MG TABLET.
Who manufactures DILTIAZEM 90 MG TABLET?
DILTIAZEM 90 MG TABLET (NDC 68682000850) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.